$1.14 (-0.437%)

Volume: 11.08k

Closed: Dec 02, 2022

Hollow Logo Score: -2.450

Genetic Technologies Ltd Stock Forecast

$1.14 (-0.437%)

Volume: 11.08k

Closed: Dec 02, 2022

Score Hollow Logo -2.450

Genetic Technologies Ltd Stock Statistics NASDAQ:GENE

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-02 - 2022-12-02 SELL 0
2022-12-01 - 2022-12-02 HOLD -0.437
2022-11-30 - 2022-12-01 SELL 2.69
2022-11-29 - 2022-11-30 HOLD -2.19
2022-11-22 - 2022-11-29 SELL 0.441

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Genetic Technologies Ltd

Genetic Technologies Ltd Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecol... GENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE